ID21755A - Antijamur azol yang mengandung ester asam amino - Google Patents

Antijamur azol yang mengandung ester asam amino

Info

Publication number
ID21755A
ID21755A IDW990505A ID990505A ID21755A ID 21755 A ID21755 A ID 21755A ID W990505 A IDW990505 A ID W990505A ID 990505 A ID990505 A ID 990505A ID 21755 A ID21755 A ID 21755A
Authority
ID
Indonesia
Prior art keywords
amino acid
antijamur
azol
acid esters
contains amino
Prior art date
Application number
IDW990505A
Other languages
English (en)
Inventor
Lieven Meerpoel
Jan Heeres
Robert Josef Maria B Hendrickx
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of ID21755A publication Critical patent/ID21755A/id

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
IDW990505A 1997-02-11 1998-02-03 Antijamur azol yang mengandung ester asam amino ID21755A (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97200374 1997-02-11
EP97203228 1997-10-15

Publications (1)

Publication Number Publication Date
ID21755A true ID21755A (id) 1999-07-22

Family

ID=26146124

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW990505A ID21755A (id) 1997-02-11 1998-02-03 Antijamur azol yang mengandung ester asam amino

Country Status (31)

Country Link
US (3) US6262052B1 (id)
EP (1) EP0958289B1 (id)
JP (1) JP4347911B2 (id)
KR (1) KR100509171B1 (id)
CN (1) CN1238353C (id)
AT (1) ATE270290T1 (id)
AU (1) AU725302C (id)
BG (1) BG63872B1 (id)
BR (1) BR9809744A (id)
CA (1) CA2262791C (id)
CZ (1) CZ297197B6 (id)
DE (1) DE69824834T2 (id)
DK (1) DK0958289T3 (id)
EE (1) EE03876B1 (id)
ES (1) ES2224364T3 (id)
HU (1) HU227744B1 (id)
ID (1) ID21755A (id)
IL (2) IL128513A (id)
MY (1) MY129537A (id)
NO (1) NO316668B1 (id)
NZ (1) NZ334477A (id)
PL (1) PL191152B1 (id)
PT (1) PT958289E (id)
RU (1) RU2197489C2 (id)
SI (1) SI0958289T1 (id)
SK (1) SK284910B6 (id)
TR (1) TR199900584T2 (id)
TW (1) TW495508B (id)
UA (1) UA61919C2 (id)
WO (1) WO1998034934A1 (id)
ZA (1) ZA981079B (id)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0957101A1 (en) * 1998-05-14 1999-11-17 Janssen Pharmaceutica N.V. Water soluble azoles as broad-spectrum antifungals
WO2000030655A1 (en) 1998-11-20 2000-06-02 Bristol-Myers Squibb Company Water soluble prodrugs of azole compounds
BR0010279A (pt) * 1999-05-04 2002-05-14 Janssen Phamaceutica N V éteres antifúngicos
WO2003052117A2 (en) * 2001-09-19 2003-06-26 Massachusetts Institute Of Technology Methods and products related to non-viral transfection
ITMI20032020A1 (it) * 2003-10-17 2005-04-18 Italfarmaco Spa Nuovi agenti antifungini azolici con diminuita interazione con i citocromi metabolici
MX342850B (es) * 2010-05-19 2016-10-14 Sandoz Ag Proceso para la preparacion de triazolonas quirales.
BR102019004480B1 (pt) * 2018-03-08 2023-03-28 Dow Agrosciences Llc Picolinamidas como fungicidas
CN111138421A (zh) * 2019-12-26 2020-05-12 上海英诺富成生物科技有限公司 抗真菌水溶性化合物及其制备方法与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4218458A (en) 1978-06-23 1980-08-19 Janssen Pharmaceutica, N.V. Heterocyclic derivatives of (4-aryloxy-methyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles
US4791111A (en) * 1985-12-23 1988-12-13 Janssen Pharmaceutica, N.V. [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles having anti-microbial properties
US4916134A (en) 1987-03-25 1990-04-10 Janssen Pharmacuetica N.V. 4-[4-[4-[4-[[2-(2,4-difluorophenyl)-2-(1H-azolylmethyl)-1,3-dioxolan-4-yl]me]phenyl]-1-piperazinyl]phenyl]triazolones
CA1331757C (en) 1988-02-29 1994-08-30 Janssen Pharmaceutica Naamloze Vennootschap 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols
NZ249494A (en) 1992-03-18 1996-04-26 Janssen Pharmaceutica Nv Itraconazole and saperconazole stereoisomers; pharmaceutical compositions
CZ294823B6 (cs) * 1993-12-21 2005-03-16 Schering Corporation Fungicidní tetrahydrofurany
SI0741737T1 (en) * 1994-01-24 2000-02-29 Janssen Pharmaceutica N.V. Watersoluble azole antifungals
AR002751A1 (es) 1995-06-02 1998-04-29 Schering Corp Antifungicos de tetrahidrofurano, composiciones farmaceuticas que los contienen y el uso de los compuestos para preparar composiciones farmaceuticas utiles para el tratamiento de infecciones fungicas
WO1997000255A1 (en) * 1995-06-19 1997-01-03 Schering Corporation Tetrahydrofuran antifungals

Also Published As

Publication number Publication date
IL128513A0 (en) 2000-01-31
CZ297197B6 (cs) 2006-09-13
HUP0001050A3 (en) 2001-07-30
AU725302B2 (en) 2000-10-12
EP0958289B1 (en) 2004-06-30
KR20000068526A (ko) 2000-11-25
BG63872B1 (bg) 2003-04-30
US6703506B2 (en) 2004-03-09
NO990484L (no) 1999-10-11
EE03876B1 (et) 2002-10-15
CA2262791C (en) 2008-10-28
BG103171A (en) 1999-09-30
MY129537A (en) 2007-04-30
WO1998034934A1 (en) 1998-08-13
DE69824834T2 (de) 2005-07-21
US6512116B2 (en) 2003-01-28
PL191152B1 (pl) 2006-03-31
IL149285A0 (en) 2002-11-10
US6262052B1 (en) 2001-07-17
DK0958289T3 (da) 2004-11-01
US20010039281A1 (en) 2001-11-08
HUP0001050A2 (hu) 2001-04-28
JP2001508080A (ja) 2001-06-19
AU6620798A (en) 1998-08-26
RU2197489C2 (ru) 2003-01-27
NO316668B1 (no) 2004-03-29
PT958289E (pt) 2004-11-30
AU725302C (en) 2001-08-23
EP0958289A1 (en) 1999-11-24
IL128513A (en) 2002-11-10
SK105999A3 (en) 2000-06-12
JP4347911B2 (ja) 2009-10-21
NO990484D0 (no) 1999-02-02
SK284910B6 (sk) 2006-02-02
CN1236366A (zh) 1999-11-24
ZA981079B (en) 1999-08-10
TW495508B (en) 2002-07-21
DE69824834D1 (de) 2004-08-05
ATE270290T1 (de) 2004-07-15
CZ283599A3 (cs) 2000-02-16
BR9809744A (pt) 2000-06-20
CN1238353C (zh) 2006-01-25
CA2262791A1 (en) 1998-08-13
ES2224364T3 (es) 2005-03-01
SI0958289T1 (en) 2004-12-31
US20030158210A1 (en) 2003-08-21
PL332008A1 (en) 1999-08-16
NZ334477A (en) 2001-05-25
UA61919C2 (uk) 2003-12-15
EE9900100A (et) 1999-10-15
TR199900584T2 (xx) 1999-10-21
KR100509171B1 (ko) 2005-08-22
HU227744B1 (en) 2012-02-28
IL149285A (en) 2007-08-19

Similar Documents

Publication Publication Date Title
MXPA02005536A (es) Acidos aminopropilfosfinicos novedosos.
DE69727956D1 (de) Pharmazeutische zubereitungen zur verminderung von atmungsdepressionen
AU8985391A (en) Trifluoromethylketone derivatives, processes for preparation thereof and use thereof
RS50046B (sr) Farmaceutske kompozicije tizoksanida i nitazoksanida
ID21755A (id) Antijamur azol yang mengandung ester asam amino
AU5879798A (en) Agents inhibiting progress of pterygium and postoperative recurrence of the same
RU95113437A (ru) (h±)-сложный этиловый эфир транс-2-диметиламино-1-фенил-3-циклогексентранс-1-карбоновой кислоты в виде первичного ортофосфата и твердая фармацевтическая композиция с обезболивающей активностью
DE69330601T2 (de) Serotoninergische ergolin derivate
ITMI932189A1 (it) Composizioni farmaceutiche contenenti n-acetilcarnosina per il trattamento della cataratta
RS49520B (sr) Antimikrobno aktivne smeše
GEP20032975B (en) Echinocandin Derivatives, Preparation Method and Pharmaceutical Composition
ES2094608T3 (es) Mezclas fungicidas.
IL111138A (en) Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia
ES8104271A1 (es) Procedimiento para la preparacion de 5-(2-((3-(1,3-benzodio-sol-5-il)-1-metilpropil)amino)-1-hidroxietil-2-metoxibenza- mida y de sus sales e isomeros opticos farmaceuticamente aceptables
YU47871B (sh) Derivati aminokiselina
NO931091L (no) Analoger av sykloinopeptid a og anvendelse derav